Emmanuel J Favaloro/LinkedIn
Dec 16, 2025, 13:00
ScholarGPS Ranks Emmanuel J. Favaloro No. 1 in the World for Hemostasis
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared a post on LinkedIn:
“The ScholarGPS database has been updated. Honored to be ranked No. 1 in the World in lifetime category for the field of Hemostasis; 4th in the world for both Thrombosis and von Willebrand disease. Take a look to see if you are on the list.”

-
Nov 19, 2026, 07:00Rucha Patil: Haematocon 2026 – Advancing Haematology Through Science, Collaboration and New Connections
-
Nov 19, 2026, 06:20Suvro Sankha Datta: AABB Releases the 8th Edition of Molecular Testing Standards
-
Nov 19, 2026, 05:54Global Collaboration in Hemostasis – ISTH
-
Nov 19, 2026, 05:40Pete Stibbs: Advancing Treatment Strategies in Venous Disease
-
Nov 19, 2026, 05:31Lance Reed: One Donation, Multiple Lives
-
Nov 19, 2026, 05:20ZPI Silencing as a Novel Non-Factor Therapy for Rare Bleeding Disorders – HITh
-
Nov 19, 2026, 04:48Antiphospholipid Antibodies and Stroke Management – RPTH
-
Nov 18, 2026, 20:58Uma Vaidyanathan: When Hemoglobin Does Not Respond to Iron Therapy, Look Beyond Iron Deficiency
-
Nov 18, 2026, 20:57Jamil Rafiq: 5 Ways to Prevent Sample Haemolysis